Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Serum and gene expression profile of cytokines following combination of yoga training and vitamin D supplementation in breast cancer survivors: a randomized controlled trial

BMC Women's Health volume 22, Article number: 90 (2022) Cite this article

Abstract

Background

This study aimed to examine the effect of the combination of yoga training with high vitamin D dose supplementation on the expression and systemic levels of inflammatory cytokines and psychophysical status of breast cancer survivors.

Methods

Thirty volunteered breast cancer survivors (48 ± 8 years) were randomly allocated to a high dose (4000 IU) of vitamin D supplementation (HD) group (n = 10), yoga with a high dose of vitamin D (YHD) group (n = 10), and yoga with a low dose (2000 IU) of vitamin D (YLD) group (n = 10). Participants performed the Hatha yoga style for 12 weeks, twice a week. Blood samples, quality of life (QoL) questionnaire, and physical performance tests were taken before and after the intervention.

Results

Body fat percentage (ηp2 = 0.36), handgrip strength (ηp2 = 0.41) and QoL indicators include global health (ηp2 = 0.54), functional scales (ηp2 = 0.49), and symptoms scales (ηp2 = 0.50) were significantly improved in the both YHD and YLD groups compared to the HD group (p < 0.05). Also, interleukin-10 (IL-10) levels were markedly increased in the Y-HVD group compared to the Y-LVD and HVD groups. Moreover, there were significant decreases in tumor necrosis factor-α (TNF-α) and interleukin-6 levels in the Y-HVD group after the intervention. The anti-inflammatory index (IL-10/TNF-α) was significantly increased in both the yoga groups (P < 0.05).

Conclusion

Yoga promotes physical and psychological fitness and, in combination with a high dose of vitamin D, improves the cytokine profile, which can effectively manage the side effects associated with cancer.

Trial registration IRCT20210726051993N2. Registration date: 2022/02/27. URL: https://www.irct.ir/trial/62079

Peer Review reports

Background

Breast cancer (BC) and treatments have several side effects on psychological and physical health, leading to a decline in the quality of life (QoL). The side effects could reduce survivors' muscle strength and aerobic capacity [1] and expose patients to psychiatric disorders such as depression and anxiety [2]. Fatigue is a common side effect of cancer treatment associated with decreased physical activity, which subsequently reduces functional abilities.

There are several lines of evidence linking fatigue to elevated pro-inflammatory cytokines in cancer survivors [3, 4]. In particular, serum levels of interleukin-6 (IL-6) [5] and tumor necrosis factor-α (TNF-α) [6] may be increased as part of the host response to tissue damage or cancer treatments. Even though IL-10 is considered an anti-inflammatory cytokine, a dual role of IL-10 in breast cancer development was reported [7]. The IL-10/TNF-α ratio is widely used as an anti-inflammatory status [8] and metabolic diseases [9]; thus, this ratio would be a better indicator of the treatment process. However, peripheral blood mononuclear cells (PBMCs) are considered the primary source of pre-and anti-inflammatory cytokines; they are involved in changes in serum cytokine profiles [10]. It appears that investigating inflammatory markers-related gene expression in PBMCs may predict their changes in different cancer stages more accurately [11]. It is suggested that behavioral modifications such as exercise and a healthy diet effectively regulate cytokine balance and manage adverse side effects [12, 13].

Many BC patients and survivors, especially at menopause, have deficiencies in nutritional indicators, including vitamin D (VD) [14, 15]. Vitamin D deficiency is associated with a decline in QoL [16], worsens cancer prognosis, and increases the mortality rate in cancer patients [14, 17]. However, more studies are needed on the VD doses that can be used to improve the QoL, especially in cancer survivors. Immune regulatory effects of VD supplementation, particularly in high doses was observed in some studies [18, 19]. Mechanistically, VD supplementation could lead to a shift from a Th1 to a Th2 phenotype [20], and enhance IL-10 gene expression in T cells [21], which in turn inhibits the production of pro-inflammatory cytokines.

Exercise training is a behavioral modification to alleviate the side effects of cancer and its treatments. Yoga is a body-mind exercise that combines physical, mental, and spirit to improve psychological and physical health. Hatha yoga, the most common style executed in therapeutic settings, includes physical exercises (Asanas), breathing techniques (Pranayama), and meditation (Dyana) [22, 23]. A systematic review reported that chronic stress via dysfunction in the classic neuroendocrine system and the sympathetic nervous system could induce tumorigenesis and promote cancer development [24]. Thus, stress management is crucial for cancer patients. Although the results are contradictory, it has been shown that yoga dampens inflammatory markers [25], stress and anxiety [26, 27], and fatigue [28] in cancer survivors; hence, yoga appears to be an appropriate approach to improving the QoL of women with breast cancer. Furthermore, some studies showed that yoga could have a regulatory effect on the nervous system [23]. Declined sympathetic nervous system tone [23, 29], and increased vagal activity [29] are of mechanistic factors observed in yoga’s benefits, both of which are involved in favorable endocrine and immune system changes that could lower inflammation markers. Therefore, in addition to improving physical and psychological fitness, yoga therapies could reduce inflammatory responses [25].

A combination of exercise training and antioxidant supplementation in high doses can be effective on anti-tumor immunology and inflammatory cytokines [30]. However, considering the immune system's changes, the simultaneous effect of exercise training and VD intake has not been fully elucidated. Overall, given that a high dose of VD is safe for women at higher risk of BC [31] and recommended for BC survivors to reduce inflammatory markers, yoga also plays an influential role in this process; we hypothesized that combining yoga exercise training and high VD dose can be more effective on expression and systemic levels of inflammatory cytokines. For approving our hypothesis, the effects of the combination of low VD dose and yoga exercise training on inflammatory cytokines were assessed in the current study. Moreover, inflammatory responses were associated with the psychological situation of breast cancer. Here, we assessed the possible relation between psychological indices and inflammatory expression in PBMCs and systemic levels of inflammatory cytokines in BC survivors.

Methods

The experimental approach to the problem

This randomized controlled trial, single-blinded, and parallel groups aimed to determine the effectiveness of 12 weeks of yoga training combined with VD supplementation on QoL and inflammatory markers in BC survivors. A few oncologists introduced eligible participants to participate in the study. Initially, based on the initial level of VD, the participants were divided into three groups randomly by a third person who was not in the research group. Pre- and post-intervention, QoL questioner, and handgrip strength tests were performed by the third assessor. Venous blood samples were collected to measure IL-6, IL-10, and TNF-α and their gene expressions in leukocytes. A schematic overview of the study is presented in Fig. 1.

Fig. 1
figure 1

Schematic overview of study timeline (CONSORT flow diagram)

Full size image

Participants

Following an initial meeting to discuss the objectives of this research project with oncologists, they referred the participants to the research team. Inclusion criteria were described in our previous study [32]. The history of BC survivors is presented in Table 1. Briefly, the tumor type of survivors was carcinoma in situ (stage 0), IA& IB stage, and IIA based on the TNM staging system. The sample size was calculated by using G*Power Software as described in our previous study [32]. Thirty-three BC survivors who met inclusion criteria volunteered to participate in the study, but the data of 30 participants (age: 47.90 ± 7.95 years; height: 160.93 ± 6.12 cm, body mass: 72.62 ± 11.72 kg) were obtained and analyzed finally. Three participants were excluded from the study as described in Fig. 1 and our previous study [32]. A third person randomly divided participants into three groups based on a simple block random method (6 blocks), including a high dose (4000 IU) of VD supplementation (HVD) group (n = 10), yoga with a high dose (4000 IU) of VD (Y-HVD) group (n = 10), and yoga with a low dose (2000 IU) of VD (Y-LVD) group (n = 10). It seems that we needed a group that only practices yoga, but all cancer survivors consume different doses of VD, so due to ethical reasons, we could not put that group.

Table 1 Survivor characteristics according to breast cancer subtypes
Full size table

Measurements

Physical measurements

A third person who was not a member of the research team conducted all measurements. Height, weight, and body fat percentage were measured as described in our previous research [32].

Handgrip strength tests

A hand dynamometer with an adjustable grip (TKK 5101 Grip D; Takey, Tokyo, Japan) was used to assess handgrip strength. Participants performed two attempts with both hands, while arms were fully extended, forming an angle of 30° with respect to the trunk. The maximum score in kilograms for each hand was recorded, and the mean score of both hands was used in the statistical analyses.

Quality of life

European Organization for Research and Treatment of Cancer Questionnaire (EORTC- QLQ-C30) was developed to assess the quality of life of cancer patients. The validity and reliability of this questionnaire were confirmed in the Iranian cancer population [33]. It consists of 30 questions that assess the global health, symptoms (fatigue, pain, nausea, and vomiting), and functional (physical, role, cognitive, emotional, and social) scales. Higher scores in global health and functional scales and a lower score in symptoms indicate better situations [34].

Vitamin D supplementation

Participants received a dose of VD tablets according to our previous article [32]. Briefly, participants in the HVD and Y-HVD groups received VD tablets at 4000 IU daily, and individuals in the Y-LVD group received 2000 IU daily.

Yoga protocol

A female certified yoga coach conducted yoga classes. Participants performed yoga according to our previous article [32]. Briefly, they performed yoga twice a week, for twelve weeks. Exercises were selected from the Hatha yoga style and included Asana (physical postures), pranayama (breath control), and Dyana (meditation). The yoga exercises begun with Pranayama (yoga mudra, Respiratory coordination), then asana (such as Marjaryasana cycle, Balasana, Hindolasana, Bhujangasana, Setu Bandha, Bitilasana, Surya namaskar, Baddha Konasana, Chakki Chalanasana, Utkatasana, Supta Baddha Konasana, Bhujangasana, kriya cycle, Salabhasana, Ardha Pavana Muktasana, Pavanamuktasana, suptaVakra Asana) and ended with dyana (Savasana). Each class lasted around 60–90 min; the yoga class started with 60 min and progressively increased 15 min each month to reach 90 min over the course. In order to monitor the intensity of yoga, the Borg Rating of Perceived Exertion (RPE) scale (6–20 score) was gathered after finishing every workout. The participants were asked to express their effort and exertion from the yoga practice. The Borg scale has a range from 6 to 20 (with 6 being no exertion at all and 20 being maximum effort). In general, the average score of the Borg scale was 8–14. The intensity of initial sessions was low (7–10 scores) and progressively reached moderate intensity towards (13–15) the end of the protocol.

Cytokines assessments

A medical laboratory expert collected the blood samples (5 cc for separating serum, 2.5 cc in a tube containing Ethylenediaminetetraacetic acid (EDTA) for extracting PBMCs) in overnight fasting from an antecubital vein. Samples were spun at 3000 rpm in a 4 °C centrifuge for 10 min, and separated serum was stored a −20 °C. Specific human enzyme-linked immunosorbent assay [ELISA] kits were used to determine the serum level of IL-10 [catalog number: D1000b, R& D, US], TNF-α [catalog number DY210, R& D, US], and IL-6 [catalog number D6050, R& D, US]. The intra- and inter-assay coefficients of variation were less than 8%. A buffy coat layer was removed using a suspension technic, and then RNA samples were extracted using the total RNA extraction Kit (NanoDrop Technologies/Thermo Scientific, Wilmington, DE, USA), and cDNA synthesis was performed using the Takara cDNA synthesis kit (Takara, Japan) according to the manufacturer's instructions. Real-time PCR was performed using the SYBR Green Master Mix kit (Ampliqon, Denmark). The thermal cycling program was described in our previous research [32]. GAPDH mRNA for the normalization of the gene expression analysis was used. The sequence of PCR primers used for the amplification of the protein-coding genes was as follow: IL-6 forward "GTGAGGAACAAGCCAGAGCA ", IL-6 reverse "TGGCATTTGTGGTTGGGTCA"; IL-10 forward “CTTTAAGGGTTACCTGGGTTGC", IL-10 reverse "CTCACTCATGGCTTTGTAGACAC"; TNF-α forward "CTCCCTCTCATCAGTTCCAT" and TNF-α reverse "CAGTTGGTTGTCTTTGAGATC"; GAPDH forward "CGAGATCCCTCCAAAATCAA" GAPDH reverse "AGGTCAGGTCCACCACTGAC". The fold change expression was calculated using the 2−∆∆CT formula.

Statistical analysis

Data were analyzed using SPSS software in accordance with the previous study [32]. Briefly, a paired t-test (within-group difference) and an analysis of covariance (ANCOVA) with Bonferroni post-hoc tests were used to analyze the effects of interventions on the variables. Data of gene expression changes were analyzed by ANOVA, and the magnitude and direction of the linear relationship between circulatory markers with anthropometric indicators and QoL indicators were performed by the bivariate Pearson correlation coefficient (r). Effect sizes (ES) were calculated similarly to the previous study [32]. The changes percentage was calculated by formula: \(CP\% = \frac{{\left( {posttest - pretest} \right)}}{pretest} \times 100\). The significance level was set at p ≤ 0.05 for all statistical analyses.

Results

Physical and Psychological status

The descriptive data of performance and psychological variables are presented in Table 2. There were no significant differences between groups in all indices at baseline (p > 0.05). Although there was a substantial decrease in body mass in both groups who performed yoga, there were no significant differences between groups (F = 2.9, p < 0.070, ηp2 = 0.19). A 12-week intervention significantly decreased body fat percentage (BF%) in the Y-HVD and Y-LVD groups compared to the HVD group with a moderate effect size (F = 7.2, p < 0.003, ηp2 = 0.36). Handgrip strength was measured as a physical indicator. We observed a significant difference between groups at handgrip strength (F = 8.9, p = 0.001, ηp2 = 0.41) with a moderate effect size. However, yoga is not considered a strength-enhancing exercise. The Bonferroni post hoc test showed the handgrip strength test was significantly increased in both yoga groups than in other groups (p < 0.05). In addition, we observed significant differences in the QoL questionnaire between groups at global health (F = 15.0, p < 0.001, ηp2 = 0.54), functional scales (F = 12.9, p < 0.001, ηp2 = 0.49), and symptoms scales (F = 13.0, p < 0.001, ηp2 = 0.50) with a moderate effect size. Three months of yoga classes effectively improved the QoL in both the Y-HVD and Y-LVD groups compared to the HVD group (Table 2).

Table 2 Performance and psychological indicators of participants before and after performing the intervention
Full size table

Vitamin D and cytokines levels

A 12-week VD supplementation period led to a significant increase in VD concentrations (F = 6.5, p = 0.005, ηp2 = 0.33). The post hoc analysis showed a significant difference was between both HD and Y + HD groups and the Y + LD group.

There were no significant differences in the circulatory level of IL-6 between groups (F = 1.2, p = 0.318, ηp2 = 0.08). Also, in intra-group changes, there was a substantial decrease in the Y-HVD group (p = 0.001, −30.9%), but there were no significant changes in the Y-LVD (p = 0.150, −16.3% and HVD group (p = 0.390, −10.2%) (Fig. 2a).

Fig. 2
figure 2

Concentration of serum IL-6 (a), TNF-α (b), IL-10 (c), and IL-10/TNF-α ratio (d) at baseline and after the intervention. HVD: a high dose of vitamin D, Y-LVD: yoga with a low dose of vitamin D, Y-HVD: yoga with a high dose of vitamin D. *Significant difference from pre-to post-intervention; #significant difference with the Y-HVD group

Full size image

Although there were significant decreases in the circulatory level of TNF-α in the Y-LVD (p = 0.034, −13.0%) and Y-HVD groups (p = 0.001, −24.7%), not in the HVD group (p = 0.149, −8.7%), these changes were not significant between groups (F = 1.6, p < 0.230, ηp2 = 0.11) (Fig. 2b).

There was a significant difference in the circulatory level of IL-10 between groups (F = 5.7, p < 0.009, ηp2 = 0.31) with a moderate effect size. The Bonferroni post hoc test showed the difference between the Y-HVD group and the other groups (p < 0.05). Serum concentration of IL10 significantly increased in the Y-HVD (p = 0.001, 61.9%), the Y-LVD (p = 0.023, 19.4%), and the HVD groups (p = 0.025, 17.0%) (Fig. 2c).

The ratio of IL-10/ TNF-α was measured as an anti-inflammatory index. There was a significant difference in the IL-10/ TNF-α ratio between groups (F = 9.3, p < 0.001, ηp2 = 0.42) with a moderate effect size. The Bonferroni post hoc test showed changes in the Y-HVD group differ significantly from the other groups (p < 0.05). In intra-group changes, there were significant increases in the Y-HVD group (p = 0.001, 117.4%), the HVD (p = 0.021, 36.6%) and Y-LVD (p = 0.030, 48.8%) groups (Fig. 2d).

Table 3 presents the correlations between circulatory markers and weight, BF%, strength, and QoL indicators. There were significant negative relations between IL-10 changes and changes in weight (r = −0.51), BF% (r = −0.38), and positive association with global health on of the QoL indicator (r = 0.52). TNF-α and IL-6 changes only demonstrated a significant positive correlation with BF% (Table 3). Significant negative correlations between IL-10/ TNF-α ratio changes and weight (r = −0.38) and BF% (r = −0.59) changes and significant positive global health changes(r = 0.42) were observed (Table 3).

Table 3 Correlation between changes in inflammatory markers and weight, body fat%, and quality of life indicator after the intervention
Full size table

Gene expression in PBMCs

Figure 2a shows the changes in IL-6 gene expression in the groups after intervention. A significant difference was observed in leukocyte's IL-6 expression between the groups (F = 3.8, p = 0.034). The Bonferroni post hoc test showed a significant difference was between the HVD group and Y-HVD. IL-6 expression upregulated in the HVD; doing yoga led to a decline in IL-6 expression (Fig. 3a).

Fig. 3
figure 3

Gene expression of IL-6 (a), TNF-α (b), IL-10 (c), and IL-10/TNF-α ratio (d) at baseline and after intervention in peripheral blood cells. HVD: a high dose of vitamin D, Y-LVD: yoga with a low dose of vitamin D, Y-HVD: yoga with a high dose of vitamin D. *Significant difference from pre-to post-intervention; #significant difference with the Y-HVD group

Full size image

Following the intervention, there were no significant differences in leukocyte's TNF-α expression between groups (F = 3.39, p = 0.075) (Fig. 3b).

In addition, a significant difference was observed in leukocyte's IL-10 expression between groups after intervention (F = 3.80, p = 0.036). Expression of IL-10 increased in all groups; the magnitude of the increase has significantly differed in the Y-HVD group and the Y-LVD group (Fig. 3c).

Interventions enhanced the anti-inflammatory index, IL-10/ TNF-α ratio, in the peripheral mononuclear cells. There were significant differences in the IL-10/ TNF-α ratio between groups (F = 23.5, p < 0.001). The Bonferroni post hoc test showed increases in the Y-HVD group (32.4%) differ significantly from the Y-LVD (11.2%) and the HVD (9.2%) groups (Fig. 3d).

Discussion

The primary aim of this study was to evaluate the effectiveness of 12 weeks of yoga training combined with high VD does supplementation on cytokine profile and QoL in BC survivors. Also, possible relations between cytokine levels with functional and psychological indices were assessed. High VD dose supplementations led to significant increases in VD level than low VD dose. The findings indicate the high amount of VD alone did not significantly improve the systemic inflammation and QoL and performance indicators. Yet, substantial improvements in QoL, handgrip strength and body composition were observed in combination with yoga. Moreover, yoga with a high VD dose led to marked increases in the circulatory level of IL-10 and decreases in the concentrations of IL-6 and TNF-α. Also, the anti-inflammatory index was increased in the yoga plus high VD dose group. These results were relatively parallel with changes in inflammatory cytokines gene expression in peripheral blood cells. In addition, there were significant correlations between circulatory markers changes, especially IL-10 and IL-10/TNF-α ratio changes, and weight and BF% changes as well as global health of QoL indicators. Moreover, our findings indicated that a combination of yoga and a low dose of VD improved QoL, handgrip strength, and body composition but did not show synergistic effects on cytokine balance in genes expression levels in peripheral blood cells and plasma levels.

The findings supported previous research demonstrating that yoga improves BC survivors' QoL [35, 36]. In this regard, Vadiraja et al. [36], in a randomized controlled trial study, showed that six weeks of yoga significantly improved emotional function, cognitive function, and reduced adverse effects, which subsequently led to an improvement in the QoL of BC patients undergoing radiotherapy. Several mechanisms are proposed for improving the QoL with yoga, including promoting physical fitness and independence, improving social behaviors and the feeling of empathy resulting from group training, and reducing anxiety [37]. Interestingly, the improved QoL coincided with improving body composition and handgrip strength and boosting the immune system by lowering systemic inflammation.

Cancer-related fatigue and its treatments are associated with low activity resulting in adverse effects on body composition and muscle atrophy, leading to a decline in BC survivors' QoL. Elevated body mass via increased BF% could intensify sedentary behaviors and causes complications such as metabolic diseases. On the other hand, exercise interventions like yoga can increase energy expenditure as long as the energy intake is constant, leading to losing weight by burning fat and positively affecting body composition [38,39,40,41]. Our finding supported previous studies and showed that a 12-week yoga practice period reduced BF% by 4.7% and 3.9% in the Y-LVD and Y-HVD groups, respectively. In addition, decreased muscle strength is another complication of sedentary behaviors. It was reported that handgrip strength might be an important correlate of health in BC survivors and could be an adjuvant method for evaluation function abilities [42]. We observed a marked increase in the handgrip strength in both Y-HVD (7.1%) and Y-LVD (13.3%) groups. In this regard, substantial improvements in handgrip strength have been reported in patients with rheumatoid arthritis [43] and the affected side in BC patients [44] with yoga exercises. Yoga movements include stretching and muscular endurance exercises that can inherently enhance strength by promoting neuromuscular coordination, especially in those who have experienced extreme muscle weakness. Therefore, yoga as an exercise intervention is effective in lowering BF% and improving muscle strength.

Improved the QoL of the participants was associated with a reduction in systemic inflammation indicators and an improvement in the anti-inflammatory index. Following the intervention, the IL-6 gene expression in PBMCs increased in the HVD group, but yoga led to decreased it in both Y-LVD and Y-HVD groups; serum concentrations of IL-6 were reduced in all groups, but only it was significantly reduced in the Y-HVD group (30%). In this regard, Long parma et al. (2015) also stated that six months of yoga did not affect inflammatory serum markers such as IL-6, IL-8, and TNF-α [41]. In contrast, some researchers reported yoga could lower inflammatory markers, IL-6, and TNF-α [25, 45, 46]. However, little is known about mechanisms underlying reducing inflammatory markers with yoga, reducing BF%, and increasing in parasympathetic nervous system via the anti-inflammatory cholinergic pathway [47] lead to reduce inflammation. The observed significant positive correlation (r = 0.43) between IL-6 changes and BF% changes approved that reducing fat tissue with the combination of yoga with low and high VD doses was involved in decreasing IL-6 levels. In addition, given most BC survivors report problems with sleep [48] and sleep disturbance can activate inflammatory signaling, improve sleep quality with yoga might account for lowering inflammatory markers in BC survivors. On the other hand, VD can suppress the production of the pro-inflammatory cytokine, IL-6, through inhibition of p38 activation and cytokine production in leukocytes [49], as well as down-regulation of NF-κB expression in human lymphocytes [50]; thus, the greatest impact on reducing IL-6 was seen in the Y-HVD group. In addition, a systematic review proposed that possible effects of VD supplementation could induce auto-immunity effects with increasing regulatory T activity and suppressing Th17 responses [51].

Also, we observed a significant increase in the anti-inflammatory index, the IL-10/ TNF-α ratio, in the Y-HVD group compared to other groups following the intervention in the serum and gene expression levels. This change was due to a marked increase in an anti-inflammatory cytokine, IL-10, and a non-significant decrease in a pro-inflammatory cytokine, TNF-α. In this regard, researchers reported no significant changes in serum TNF-α levels after 10–12 weeks of yoga training [45, 46, 52] and a considerable increase in serum IL-10 levels after 12 weeks of yoga [53]. Researchers have attributed these improvements to the anti-inflammatory effects of exercise training [54] and to burning fat tissue [40]. Researchers reported that increased production of IL-10, an anti-inflammatory cytokine, leads to inhibition of the synthesis of pro-inflammatory cytokines, including TNF-α as well as its receptors [55, 56]. Also, the observed substantial correlations between IL-10 (r = −0.38) and TNF-α (r = 0.36) changes and BF% prove that a decrease in adipose tissue is involved at serum levels of these cytokines. Moreover, VD could suppress TNF-α production through inhibition of p38 activation [49] and down-regulation of NF-κB expression in human leukocytes [50] and regulate the IL-10 gene expression in human B cells, increasing serum IL-10 level [57]. In this study, a further increase in IL-10 gene expression in the HVD (2.6 fold) and Y-HVD (4.4 fold) groups compared to the Y-LVD group (1.8 fold) indicated that high VD dose has noticeable anti-inflammatory effects. On the other hand, it seems that the degree of adaptations is intensity-dependent. Given that moderate-intensity aerobic training led to a greater reduction in TNF-α levels than low-intensity exercise [58], it might need to perform yoga with higher intensity for a significant effect.

We acknowledge that there are some limitations to this study. Firstly, monitoring the participants' diets and determining the amount of VD intake from the diet was difficult because of the intervention duration. Secondly, individualizing the intensity of yoga in a group class is very difficult and complicated; however, we used the Borg scale, representing the degree of the mental and physical difficulty of the work done. Given that the intensity may be an essential factor in the concentration of inflammatory cytokines, we recommend that the effect of exercise intensity be investigated in future research. In addition, we recommend that the investigation be conducted over a longer length, and the participants would be followed up to determine the persistence of the adaptations.

Conclusions

In conclusion, receiving high doses of VD is safe and effective in reducing inflammatory markers. Also, performing yoga training effectively improves the physical and mental status and QoL of BC survivors. Therefore, combining both approaches, yoga with a high VD dose, can be used as a practical approach to balance anti- and pro-inflammatory markers and promote physical and mental fitness in cancer survivors.

Availability of data and materials

Data would be available from the corresponding author on reasonable request.

Abbreviations

BC:

Breast cancer

QoL:

Quality of life

IL-6:

Interleukin-6

IL-10:

Interleukin-10

TNF-α:

Tumor necrosis factor-α

PBMCs:

Peripheral blood mononuclear cells

VD:

Vitamin D

HVD:

High dose of VD

Y-HVD:

Yoga with a high dose of VD

Y-LVD:

Yoga with a low dose of VD

BF%:

Body fat percentage

RPE:

Rating of Perceived Exertion

ANCOVA:

Analysis of covariance

ES:

Effect sizes

References

  1. Lovelace DL, McDaniel LR, Golden D. Long-term effects of breast cancer surgery, treatment, and survivor care. J Midwifery Womens Health. 2019;64:713–24.

    Article  PubMed  Google Scholar 

  2. Tsaras K, Papathanasiou IV, Mitsi D, et al. Assessment of depression and anxiety in breast cancer patients: Prevalence and associated factors. Asian Pacific J Cancer Prevent: APJCP. 2018;19:1661–9.

    Google Scholar 

  3. Bower JE, Ganz PA, Irwin MR, et al. Fatigue and gene expression in human leukocytes: increased nf-κb and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain Behav Immun. 2011;25:147–50.

    Article  CAS  PubMed  Google Scholar 

  4. Bower JE, Ganz PA, Aziz N, et al. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosom Med. 2002;64:604–11.

    Article  PubMed  Google Scholar 

  5. Kozłowski L, Zakrzewska I, Tokajuk P, et al. Concentration of interleukin-6 (il-6), interleukin-8 (il-8) and interleukin-10 (il-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst. 1995;2003(48):82–4.

    Google Scholar 

  6. Berberoglu U, Yildirim E, Celen O. Serum levels of tumor necrosis factor alpha correlate with response to neoadjuvant chemotherapy in locally advanced breast cancer. Int J Biol Markers. 2004;19:130–4.

    Article  CAS  PubMed  Google Scholar 

  7. Hamidullah C. B, and Konwar R: role of interleukin-10 in breast cancer. Breast Cancer Res Treat. 2012;133:11–21.

    Article  CAS  PubMed  Google Scholar 

  8. Molanouri Shamsi M, Chekachak S, Soudi S, et al. Combined effect of aerobic interval training and selenium nanoparticles on expression of il-15 and il-10/tnf-α ratio in skeletal muscle of 4t1 breast cancer mice with cachexia. Cytokine. 2017;90:100–8.

    Article  CAS  PubMed  Google Scholar 

  9. Kumari R, Kumar S, Ahmad MK, et al. Tnf-α/il-10 ratio: An independent predictor for coronary artery disease in north indian population. Diabetes Metab Syndr. 2018;12:221–5.

    Article  PubMed  Google Scholar 

  10. Connolly PH, Caiozzo VJ, Zaldivar F, et al.: Effects of exercise on gene expression in human peripheral blood mononuclear cells. Journal of applied physiology (Bethesda, Md : 1985) 2004, 97:1461–9.

  11. Brenner DR, Scherer D, Muir K, et al. A review of the application of inflammatory biomarkers in epidemiologic cancer research. Cancer Epidemiol Biomarkers Prevent. 2014, 23:1729-51.

  12. Khosravi N, Stoner L, Farajivafa V, et al. Exercise training, circulating cytokine levels and immune function in cancer survivors: a meta-analysis. Brain Behav Immun. 2019;81:92–104.

    Article  CAS  PubMed  Google Scholar 

  13. Soldati L, Di Renzo L, Jirillo E, et al. The influence of diet on anti-cancer immune responsiveness. J Transl Med. 2018;16:75–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin d levels in early breast cancer. J Clin Oncol. 2009;27:3757–63.

    Article  CAS  PubMed  Google Scholar 

  15. Friedman CF, DeMichele A, Su HI, et al. Vitamin d deficiency in postmenopausal breast cancer survivors. J Womens Health (Larchmt). 2012;21:456–62.

    Article  Google Scholar 

  16. Andersen MR, Sweet E, Hager S, et al. Effects of vitamin d use on health-related quality of life of breast cancer patients in early survivorship. Integr Cancer Ther. 2019;18:1534735418822056–1534735418822056.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Peppone LJ, Rickles AS, Janelsins MC, et al. The association between breast cancer prognostic indicators and serum 25-oh vitamin d levels. Ann Surg Oncol. 2012;19:2590–9.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Liu W, Zhang L, Xu HJ, et al. The anti-inflammatory effects of vitamin d in tumorigenesis. Int J Mol Sci 2018, 19.

  19. Nonn L, Peng L, Feldman D, et al. Inhibition of p38 by vitamin d reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: Implications for prostate cancer prevention by vitamin d. Cancer Res. 2006;66:4516–24.

    Article  CAS  PubMed  Google Scholar 

  20. Boonstra A, Barrat FJ, Crain C, et al.: 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive cd4(+) t cells to enhance the development of th2 cells. J Immunol (Baltimore, Md : 1950) 2001, 167:4974–80.

  21. Barrat FJ, Cua DJ, Boonstra A, et al. In vitro generation of interleukin 10-producing regulatory cd4(+) t cells is induced by immunosuppressive drugs and inhibited by t helper type 1 (th1)- and th2-inducing cytokines. J Exp Med. 2002;195:603–16.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Bower JE, Woolery A, Sternlieb B, et al. Yoga for cancer patients and survivors. Cancer Control. 2005;12:165–71.

    Article  PubMed  Google Scholar 

  23. Riley D. Hatha yoga and the treatment of illness. Altern Ther Health Med. 2004;10:20–1.

    PubMed  Google Scholar 

  24. Dai S, Mo Y, Wang Y, et al. Chronic stress promotes cancer development. Front Oncol. 2020;10:1492–1492.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kiecolt-Glaser JK, Christian L, Preston H, et al. Stress, inflammation, and yoga practice. Psychosom Med. 2010;72:113–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Jong MC, Boers I, Schouten van der Velden AP, et al.: A randomized study of yoga for fatigue and quality of life in women with breast cancer undergoing (neo) adjuvant chemotherapy. J Altern Complem Med (New York, NY) 2018, 24:942–953.

  27. Balaji P, Varne SR, Ali SS. Physiological effects of yogic practices and transcendental meditation in health and disease. N Am J Med Sci. 2012;4:442.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Taso C-J, Lin H-S, Lin W-L, et al. The effect of yoga exercise on improving depression, anxiety, and fatigue in women with breast cancer: a randomized controlled trial. J Nurs Res. 2014;22:155–64.

    Article  PubMed  Google Scholar 

  29. Bernardi L, Sleight P, Bandinelli G, et al. Effect of rosary prayer and yoga mantras on autonomic cardiovascular rhythms: comparative study. BMJ. 2001;323:1446–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Molanouri Shamsi M, Hassan ZM. Chapter 42 - exercise, selenium, and cancer cells. In: Preedy VR, Patel VB, editors. Cancer (second edition). San Diego: Academic Press; 2021. p. 475–82.

    Google Scholar 

  31. Crew KD, Xiao T, Thomas PS, et al. Safety, feasibility, and biomarker effects of high-dose vitamin d supplementation among women at high risk for breast cancer. Int J Food Sci Nutr Dietetics. 2015;2015:1–16.

    CAS  Google Scholar 

  32. Khedmati Zare V, Javadi M, Amani-shalamzari S, et al. The high dose of vitamin d supplementation combined with yoga training improve the leukocytes cell survival-related gene expression in breast cancer survivors. Nutr Metab. 2021;18:80.

    Article  CAS  Google Scholar 

  33. Montazeri A, Harirchi I, Vahdani M, et al. The european organization for research and treatment of cancer quality of life questionnaire (eortc qlq-c30): translation and validation study of the iranian version. Support Care Cancer. 1999;7:400–6.

    Article  CAS  PubMed  Google Scholar 

  34. Invernizzi M, de Sire A, Lippi L, et al. Impact of rehabilitation on breast cancer related fatigue: a pilot study. Front Oncol 2020, 10.

  35. Vardar Yağlı N, Şener G, Arıkan H, et al. Do yoga and aerobic exercise training have impact on functional capacity, fatigue, peripheral muscle strength, and quality of life in breast cancer survivors? Integr Cancer Ther. 2015;14:125–32.

    Article  PubMed  Google Scholar 

  36. Vadiraja HS, Rao MR, Nagarathna R, et al. Effects of yoga program on quality of life and affect in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Complement Ther Med. 2009;17:274–80.

    Article  CAS  PubMed  Google Scholar 

  37. Ülger Ö, Yağlı NV. Effects of yoga on the quality of life in cancer patients. Complement Ther Clin Pract. 2010;16:60–3.

    Article  PubMed  Google Scholar 

  38. Hughes DC, Darby N, Gonzalez K, et al. Effect of a six-month yoga exercise intervention on fitness outcomes for breast cancer survivors. Physiother Theory Pract. 2015;31:451–60.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Littman AJ, Bertram LC, Ceballos R, et al. Randomized controlled pilot trial of yoga in overweight and obese breast cancer survivors: Effects on quality of life and anthropometric measures. Support Care Cancer. 2012;20:267–77.

    Article  PubMed  Google Scholar 

  40. Cramer H, Thoms MS, Anheyer D, et al. Yoga in women with abdominal obesity—a randomized controlled trial. Dtsch Arztebl Int. 2016;113:645.

    PubMed  PubMed Central  Google Scholar 

  41. Long Parma D, Hughes DC, Ghosh S, et al. Effects of six months of yoga on inflammatory serum markers prognostic of recurrence risk in breast cancer survivors. Springerplus. 2015;4:143.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Cantarero-Villanueva I, Fernandez C, Diaz Rodriguez L, et al. The handgrip strength test as a measure of function in breast cancer survivors relationship to cancer-related symptoms and physical and physiologic parameters. Am J Phys Med Rehabil. 2012;91:774–82.

    Article  PubMed  Google Scholar 

  43. Dash M, Telles S. Improvement in hand grip strength in normal volunteers and rheumatoid arthritis patients following yoga training. Indian J Physiol Pharmacol. 2001;45:355–60.

    CAS  PubMed  Google Scholar 

  44. Mazor M, Lee JQ, Peled A, et al. The effect of yoga on arm volume, strength, and range of motion in women at risk for breast cancer-related lymphedema. J Altern Complementary Med. 2018;24:154–60.

    Article  Google Scholar 

  45. Kiecolt-Glaser JK, Bennett JM, Andridge R, et al. Yoga’s impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2014;32:1040–9.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Bower JE, Greendale G, Crosswell AD, et al. Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology. 2014;43:20–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009;9:418–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Savard J, Simard S, Blanchet J, et al. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–90.

    Article  CAS  PubMed  Google Scholar 

  49. Zhang Y, Leung DY, Richers BN, et al.: Vitamin d inhibits monocyte/macrophage proinflammatory cytokine production by targeting mapk phosphatase-1. J Immunol (Baltimore, Md : 1950) 2012, 188:2127–35.

  50. Geldmeyer-Hilt K, Heine G, Hartmann B, et al. 1,25-dihydroxyvitamin d3 impairs nf-κb activation in human naïve b cells. Biochem Biophys Res Commun. 2011;407:699–702.

    Article  CAS  PubMed  Google Scholar 

  51. Fisher SA, Rahimzadeh M, Brierley C, et al.: The role of vitamin d in increasing circulating t regulatory cell numbers and modulating t regulatory cell phenotypes in patients with inflammatory disease or in healthy volunteers: a systematic review. PLoS One 2019, 14:e0222313.

  52. Nugent NR, Brick L, Armey MF, et al.: Benefits of yoga on il-6: Findings from a randomized controlled trial of yoga for depression. Behavioral medicine (Washington, DC) 2019:1–10.

  53. Rajbhoj PH, Shete SU, Verma A, et al.: Effect of yoga module on pro-inflammatory and anti-inflammatory cytokines in industrial workers of lonavla: a randomized controlled trial. Journal of clinical and diagnostic research: JCDR 2015, 9:CC01.

  54. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol. 2005;78:819–35.

    Article  CAS  PubMed  Google Scholar 

  55. Braun DA, Fribourg M, Sealfon SC. Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (stat3) activation. J Biol Chem. 2013;288:2986–93.

    Article  CAS  PubMed  Google Scholar 

  56. Starkie R, Ostrowski SR, Jauffred S, et al. Exercise and il-6 infusion inhibit endotoxin-induced tnf-α production in humans. FASEB J. 2003;17:1–10.

    Article  Google Scholar 

  57. Heine G, Niesner U, Chang HD, et al. 1, 25-dihydroxyvitamin d3 promotes il-10 production in human b cells. Eur J Immunol. 2008;38:2210–8.

    Article  CAS  PubMed  Google Scholar 

  58. Abd El-Kader S, Gari A, Salah El-Den A. Impact of moderate versus mild aerobic exercise training on inflammatory cytokines in obese type 2 diabetic patients: a randomized clinical trial. Afr Health Sci. 2013;13:857–63.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We want to acknowledge all participants and a yoga teacher of Payammehr yoga center who collaborated with us.

Funding

There was no funding support.

Author information

Authors and Affiliations

  1. Departement of Exercise Physiology, Faculty of Physical Education and Sports Sciences, Kharazmi University, Tehran, Iran

    Mahdi Naderi, Hajar Kordestani, Zahra Sahebi & Vahid Khedmati Zare

  2. Department of Exercise Physiology, Faculty of Physical Education and Sports Science, Kharazmi University, Tehran, Iran

    Sadegh Amani-Shalamzari

  3. School of Nutrition and Dietetics, Faculty of Pure and Applied Science, Acadia University, Wolfville, NS, Canada

    Mojtaba Kaviani

  4. Working Group Exercise Oncology, Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Heidelberg, Germany

    Joachim Wiskemann

  5. Department of Physical Education and Sport Sciences, Faculty of Humanities, Tarbiat Modares University, Tehran, Iran

    Mahdieh Molanouri Shamsi

Authors
  1. Mahdi Naderi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hajar Kordestani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zahra Sahebi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Vahid Khedmati Zare
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sadegh Amani-Shalamzari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mojtaba Kaviani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joachim Wiskemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mahdieh Molanouri Shamsi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

S-AS, MK, and MM-S designed the study. MN, HK, ZS, and VKZ conducted the intervention and extracted data. SA-S analyzed the data. MM-S, S-AS, and MK interpreted the data for the study. SA-S, MK, and MM-S wrote the first draft, and JW revised it. All authors read and approved the final version of the manuscript.

Corresponding author

Correspondence to Sadegh Amani-Shalamzari.

Ethics declarations

Ethics approval and consent to participate

The ethics committee of the Sport Sciences Research Institute of Iran (approval number: IR.SSRI.REC.1398.111) approved all research procedures, and this study was conducted under the Declaration of Helsinki. After being informed of the benefits and risks of research, participants signed written consent. In addition, this research was registered (2022/02/27) in the Iranian Registry of Clinical Trials (IRCT) with registration number: IRCT20210726051993N2.

Consent for publication

Not Applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naderi, M., Kordestani, H., Sahebi, Z. et al. Serum and gene expression profile of cytokines following combination of yoga training and vitamin D supplementation in breast cancer survivors: a randomized controlled trial. BMC Women's Health 22, 90 (2022). https://doi.org/10.1186/s12905-022-01671-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-022-01671-8

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us